Log In
BCIQ
Print this Print this
 

NT1

  Manage Alerts
Collapse Summary General Information
Company Neurotez Inc.
DescriptionSmall peptide that block the PS1/CLIP-170 interaction
Molecular Target Presenilin 1 (PSEN1) (PS1) ; CAP-GLY domain containing linker protein 1 (CLIP1) (CLIP-170)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat familial Alzheimer's disease (FAD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today